Immunovision Technologies entered the industry of In Vivo Diagnostics in 1999 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 325412, which describes it as a In Vivo Diagnostics. For further clarification, the SIC classifies this business under the code 2835 and described it as a In Vivo Diagnostics. The business provides service to the B2B market.
To acquire more information, please contact James Guo by calling No number given during business hours. You can also write to the business’ Single Location at 1706 Forest View Avenue, Burlingame, California CA 94010. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Immunovision Technologies |
| Representative: | James Guo |
| Place of Business: | 1706 Forest View Avenue, Burlingame, CA 94010 |
| Contact Number: | No number given |
| Type of Service: | In Vivo Diagnostics |
| SIC Number: | 2835 |
| NAICS Number: | 325412 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1999 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Immunovision Technologies is a company operating from San Mateo, California providing professional In Vivo Diagnostics and relevant B2B variables. It was founded in 1999 and registered with the SIC code 2835 as In Vivo Diagnostics, and with the NAICS code 325412 as In Vivo Diagnostics.
With a current employee count of 1 to 4, Immunovision Technologies has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative James Guo at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 1706 Forest View Avenue in Burlingame, California 94010 and can be engaged online through the company website at , the company Twitter , and Facebook page .